What Bellerophon Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Puissance Capital Management Lp | 10% owner | Oct 13 | Open-market sale · S | −1,076,841 | $0.10 | −$112K | 0 |
| Puissance Life Science Opportunities Fund Vi | 10% owner | Jun 07 | Open-market sale · S | −134,421 | $0.83 | −$112K | 1,076,841 |
| Amin Naseem | Director | Jun 07 | Grant / award · A | +47,578 | — | — | 291,865 |
| Puissance Life Science Opportunities Fund Vi | 10% owner | May 18 | Open-market sale · S | −560,000 | $9.46 | −$5.3M | 1,211,262 |
| Kim Bobae | VP Reg. Affairs & Quality | May 18 | Open-market sale · S | −9,455 | $10.00 | −$94.6K | 1,723 |
| Kim Bobae | VP Reg. Affairs & Quality | May 18 | Exercise / conversion · M | +1,022 | $7.50 | +$7.67K | 1,723 |
| Kim Bobae | VP Reg. Affairs & Quality | May 18 | Exercise / conversion · M | +266 | $7.35 | +$1.96K | 1,723 |
| Amin Naseem | Director | Feb 10 | Grant / award · A | +84,000 | — | — | 244,287 |
| Fernandes Peter | PRINCIPAL EXECUTIVE OFFICER | Dec 09 | Withheld — tax / exercise cost · F | −9,985 | $0.93 | −$9.29K | 22,515 |
| Fernandes Peter | PRINCIPAL EXECUTIVE OFFICER | Dec 09 | Exercise / conversion · M | +32,500 | — | — | 32,500 |
| Shah Parag Suresh | VP OF BUSINESS OPERATIONS | Dec 09 | Withheld — tax / exercise cost · F | −7,834 | $0.93 | −$7.29K | 17,666 |
| Shah Parag Suresh | VP OF BUSINESS OPERATIONS | Dec 09 | Exercise / conversion · M | +25,500 | — | — | 25,500 |
| Dekker Martin | VP OF ENGINEERING & MANUFACTUR | Dec 09 | Withheld — tax / exercise cost · F | −7,834 | $0.93 | −$7.29K | 17,666 |
| Dekker Martin | VP OF ENGINEERING & MANUFACTUR | Dec 09 | Exercise / conversion · M | +25,500 | — | — | 25,500 |
| Laccona Nicholas | FINANCIAL OFFICER, (PFO & PAO) | Dec 09 | Withheld — tax / exercise cost · F | −5,530 | $0.93 | −$5.14K | 12,470 |
| Laccona Nicholas | FINANCIAL OFFICER, (PFO & PAO) | Dec 09 | Exercise / conversion · M | +18,000 | — | — | 18,000 |
| Amin Naseem | Director | Dec 31 | Grant / award · A | +39,032 | — | — | 160,287 |
| Puissance Life Science Opportunities Fund Vi | 10% owner | Jun 07 | Grant / award · A | +8,189 | $4.00 | +$32.8K | 1,771,262 |
| Puissance Life Science Opportunities Fund Vi | Director | Apr 26 | Grant / award · A | +609,231 | $4.00 | +$2.44M | 1,763,077 |
| Peacock Jonathan M | Director | Mar 31 | Grant / award · A | +15,308 | — | — | 157,033 |
Loading...
